BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34406185)

  • 1. Breast Carcinoma Shown on 99mTc-HYNIC-TOC Study Performed to Evaluate Tumor-Induced Osteomalacia.
    Jin X; Li F; Chen L; Jing H
    Clin Nucl Med; 2022 Feb; 47(2):197-199. PubMed ID: 34406185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO).
    Jing H; Li F; Zhong D; Zhuang H
    Clin Nucl Med; 2013 Aug; 38(8):664-7. PubMed ID: 23797229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.
    Jin X; Jing H; Li F; Zhuang H
    Clin Nucl Med; 2013 Nov; 38(11):922-4. PubMed ID: 24089059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Uptake of Brown Tumor in 99m Tc-HYNIC-TOC Scintigraphy Mimicking Postoperative Recurrence of Tumor-Induced Osteomalacia.
    Zhang Y; Wang P; Liu M; Liu Y; Jing H
    Clin Nucl Med; 2023 Nov; 48(11):978-979. PubMed ID: 37703478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
    Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
    Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-HYNIC-TOC in the Evaluation of Recurrent Tumor-Induced Osteomalacia.
    Shi X; Jing H; Li F; Zhao Y; Wang Z; Huo L
    Clin Nucl Med; 2019 Mar; 44(3):209-213. PubMed ID: 30672760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of
    Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
    Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomus Tumor of the Neck Detected With 99mTc EDDA HYNIC-TOC.
    Girotto N; Bogović-Crnčić T; Grbac-Ivanković S; Valković-Zujić P
    Clin Nucl Med; 2017 Oct; 42(10):758-760. PubMed ID: 28806247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
    Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
    Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
    Trogrlic M; Tezak S
    Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of
    Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
    Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
    Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
    Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hyperplasia shown on (99m)Tc-HYNIC-TOC scan.
    Niu N; Mao X; Jing H; Li F
    Clin Nucl Med; 2013 Apr; 38(4):294-6. PubMed ID: 23455537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
    Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
    J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of
    Chen H; Li Y; Gao X; Shen X
    Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma.
    Parisella M; D'Alessandria C; van de Bossche B; Chianelli M; Ronga G; Papini E; Mikolajczak R; Letizia C; De Toma G; Veneziani A; Scopinaro F; Signore A
    Cancer Biother Radiopharm; 2004 Apr; 19(2):211-7. PubMed ID: 15186602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).
    Sergieva S; Robev B; Dimcheva M; Fakirova A; Hristoskova R
    Nucl Med Rev Cent East Eur; 2016; 19(2):81-7. PubMed ID: 27479885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2006; 9(1):24-9. PubMed ID: 16791800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.